Allogene Therapeutics, Inc. ALLO
1.09 USD -0.09 -7.63%
As of Nov 2, 3:52 PM ET
- YTD
- -20.44%
- 1 year
- -12.10%
- Open
- 1.23
- Prev close
- 1.18
- Mkt cap
- 376.59M
- Vol
- 7.78M
- Avg vol
- 5.94M
- EPS
- -0.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.07
- High
- 1.23
- Forward P/E
- -1.50
- Beta
- 0.84
- Short ratio
- 11.46
- Inst. own
- 80.20%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 2.47
- 200-d avg
- 2.83
- 1y target
- 9.04
5D chart
Chart tools
Chart is warming up
The five-day price history for ALLO has not been loaded yet. Try again in a moment.
Altman Z-Score
-3.65 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
P/E -1.6×
P/S 0.0×
P/B 1.0×
P/FCF -2.0×
EV/EBITDA -1.9×
EV/Sales 0.0×
FCF Yield -49.5%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -65.3%
ROIC -52.8%
ROA -45.9%
Revenue -100.0%
Operating Income 24.3%
EPS (diluted) 34.1%
Free Cash Flow 25.6%
Current Ratio 7.9×
Quick Ratio 7.9×
Debt / Equity 0.3×
Net Debt / EBITDA -0.2×
Interest Coverage -192×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31